Showing results (411-420 of 533) with videos related to
Sort By:
Pageof 54
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.Annals of Neurology|July 31, 2019
Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriersAaron P Schultz, Reina W Kloet, Hamid R Sohrabi, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.Cancer|October 15, 1981
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study GroupC G Moertel, S Frytak, R G Hahn, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 30, 2025
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individualsPetrice M Cogswell, Heather J Wiste, Terry M Therneau, et al.Science Translational Medicine|July 5, 2023
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's diseaseYun Ju Sung, Chengran Yang, Joanne Norton, et al.Alzheimer'S Research & Therapy|August 5, 2022
Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin AmericaLeonel Tadao Takada, Carmen Aláez-Verson, Bhagyashri D Burgute, et al.Brain : a Journal of Neurology|October 6, 2025
Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkersLinda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 9, 2025
Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non-randomized controlled trialPablo M Bagnati, Marisol Londoño Castaño, María Laura Fernández, et al.Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.Pageof 54